Estrogen replacement modulates voltage-gated potassium channels in rat presympathetic paraventricular nucleus neurons by Seul Lee et al.
Lee et al. BMC Neuroscience 2013, 14:134
http://www.biomedcentral.com/1471-2202/14/134RESEARCH ARTICLE Open AccessEstrogen replacement modulates voltage-gated
potassium channels in rat presympathetic
paraventricular nucleus neurons
Seul Ki Lee, Pan Dong Ryu and So Yeong Lee*Abstract
Background: The hypothalamic paraventricular nucleus (PVN) is an important site in the regulation of the
autonomic nervous system. Specifically, PVN neurons projecting to the rostral ventrolateral medulla (PVN-RVLM) play
a regulatory role in the determination of the sympathetic outflow in the cardiovascular system. In the PVN-RVLM
neurons, the estrogen receptor β is expressed. However, to date, the effects of estrogen on PVN-RVLM neurons have
not been reported. The present study investigated estrogen-mediated modulation of two voltage-gated potassium
channel (Kv) subunits, Kv4.2 and Kv4.3, that are expressed predominantly in PVN neurons and the functional current of
Kv4.2 and Kv4.3, the transient outward potassium current (IA).
Results: Single-cell real-time RT-PCR analysis showed that 17β-estradiol (E2) replacement (once daily for 4 days)
selectively down-regulated Kv4.2 mRNA levels in the PVN-RVLM neurons of ovariectomized female rats. There
was no change in Kv4.3 levels. Whole-cell patch-clamp recordings demonstrated that E2 also diminished IA densities.
Interestingly, these effects were most apparent in the dorsal cap parvocellular subdivision of the PVN. E2 also shortened
a delay in the excitation of the PVN-RVLM neurons.
Conclusions: These findings demonstrate that E2 exerts an inhibitory effect on the functions of IA, potentially by
selectively down-regulating Kv4.2 but not Kv4.3 in PVN-RVLM neurons distributed in a specific parvocellular subdivision.
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The hypothalamic paraventricular nucleus (PVN) is an
important site of neuroendocrine and autonomic control
and has distinct subpopulations with different morpho-
logical and anatomical characteristics. The magnocellular
cells project to the pituitary gland, and the parvocellular
cells project to the median eminence, brain stem, and
spinal cord [1]. Within the parvocellular cells, the presym-
pathetic neurons project directly to the intermediolateral
column in the spinal cord where the sympathetic pregan-
glionic nuclei are concentrated or project indirectly via
the rostral ventrolateral medulla (RVLM) to influence car-
diovascular sympathetic outflows [2]. The RVLM contains
vasomotor neurons, which regulate tonic and phasic vaso-
motor tone [3]. Several previous studies have revealed the* Correspondence: leeso@snu.ac.kr
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reproduction in any medium, provided the orimportant role of PVN-RVLM pathways in the regulation
of the cardiovascular system [4-6].
Estrogen, a typical ovarian hormone, influences homeo-
static function, reproduction, and the immune system
[7,8]. Estrogen regulates gene transcription by binding the
nuclear estrogen receptor, which contains two subtypes, α
(ER-α) and β (ER-β) [9]. The two different subtypes have
been shown to be expressed widely in rat brain and dis-
tributed differentially across different regions of the brain,
of which PVN exclusively expresses ER-β [10]. The distri-
butional pattern of ER-β in the PVN is similar to that of
the parvocellular cells projecting to the brain stem or
spinal cord [11,12]. This similarity was confirmed by the
observation that PVN-RVLM neurons identified by retro-
grade tracing expressed ER-β [13]. The aforementioned
studies potentially indicate that PVN-RVLM neurons
could be major target cells for estrogen within the PVN
[10-13]. However, the effects of estrogen on this specific
cell population have not been studied.. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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the firing activity of PVN-RVLM neurons [14,15]. Stud-
ies have demonstrated that the transient outward potas-
sium current (IA) plays an important role in controlling
the membrane excitability and firing discharge of PVN-
RVLM neurons and that it contributes to remodeling
neuronal excitation under pathological conditions [14,16].
IA is encoded by homomultimeric or heteromultimeric
complexes of voltage-gated potassium channel (Kv) sub-
units within identical subfamilies [17,18]. Among those,
Kv1.4 and Kv4.3 have been suggested to be molecular cor-
relates of IA in PVN-RVLM neurons based on their strong
immunoreactivities [14]. The recent observation that
Kv4.3 mRNA expression decreased coincident to dimin-
ished IA in hypertensive rats [19] supports the correlation
of Kv4.3 and IA in PVN-RVLM neurons. Our previous
study showed that Kv4.2 and Kv4.3 mRNAs were abun-
dant in PVN neurons and that the differential expression
of Kv4.2 and Kv4.3 was parallel to the differences in the
delay in the onset of the first action potential [20] that is
known to be associated with IA in PVN neurons [21]. This
suggests that these subunits are closely related to IA in
PVN neurons. Taken together, Kv4.2 and Kv4.3 are most
likely molecular components underlying IA in the PVN,
including PVN-RVLM neurons.
Several studies have reported estrogenic regulation of
Kv4.2 or Kv4.3 transcript levels in tissues from distinct
organs, such as the heart [22,23] and uterus [24], as well
as in a hormone-producing brain cell line [25], indicat-
ing that Kv4.2 and Kv4.3 are widely expressed target
molecules that are modulated by estrogen. Furthermore,
these studies have shown that alternations in transcript
levels of these subunits coincide with changes in IA.
Hence, the current study hypothesized that estrogen
would modify Kv4.2 and Kv4.3 transcript levels in PVN-
RVLM neurons and investigated changes in the mRNA
levels of these subunits in the PVN-RVLM neurons of
ovariectomized female rats (OVX-rat) by 17β-estradiol
(E2) replacement using single cell real-time RT-PCR.
Additionally, the study examined alternations in the
current density and kinetic properties (activation and in-
activation) of IA using whole cell patch-clamp recording.
Methods
Animals
Sprague-Dawley female rats (n = 36, 7 wks old) were
used (Orient Bio Inc., Kyonggi-do, Korea). The rats were
maintained under a 12-hr light/dark cycle (lights on at
9:00 A.M.) and given free access to food and water until
sacrifice. Anesthesia was induced by an intraperitoneal
injection of Zoletil (25 mg/kg) and xylazine (10 mg/kg)
for the surgical procedure. Animals were bilaterally
ovariectomized (OVX). Every effort was made to minimize
the number of animals and their suffering. The experimentalprotocols were performed in accordance with the guidelines
of the Institutional Animal Care and Use Committee of
Seoul National University and were approved by the
Institute of Laboratory Animal Resources of Seoul National
University (SNU-100917-1).
Retrograde tracing
One week after OVX, the retrograde-transported fluores-
cent tracer, FluoSphere-Red (Molecular Probes, Eugene,
OR, USA), was injected into the RVLM of OVX-rats to
identify PVN-RVLM neurons, as previously described
[26]. The injection point was, on average, 12.5 mm caudal,
1.7 mm lateral, and 8.0 mm ventral from bregma. To ver-
ify that dye was injected into the RVLM, serial medulla
slices (100 μm thicknesses) of all animals subjected to
retrograde tracing were examined after sacrifice.
E2 treatment
Treatments began on the fourth day after the retrograde
tracing process. Rats were divided into two groups: the
oil-treated group (oil-group) and the 17β-estradiol-treated
group (E2-group). The treatments were given once daily
for four consecutive days prior to sacrifice and brain slice
preparation; subcutaneous injections of corn coil (0.1 ml;
Sigma-Aldrich, St. Louis, MO, USA) and 17β-estradiol-3-
benzoate (25 μg/kg in 0.1 ml corn oil; Sigma-Aldrich)
were administered to the oil-group and the E2-group, re-
spectively. The quality of treatments was assessed by com-
paring serum E2 concentrations, body weight gain rates,
and uterus weights between the two groups. Serum E2
concentrations were measured using the Estradiol ELISA
kit (Labor Diagnostika Nord GmbH & Co. KG, Nordhorn,
Germany; sensitivity, 10 pg/ml) according to the manufac-
ture’s manual. Blood samples were collected from the ab-
dominal vein of rats before sacrifice, allowed to cluster for
30–40 min at room temperature, and centrifuged for
25 min at 4°C. The serum layers were removed carefully
into new tubes, and stored in -70°C until used for the
ELISA assay. Body weight was measured before every
treatment for all animals. The ratio of increased body
weight on each day to the weight on the first day of treat-
ment was used for the body weight gain rate. Uteri were
isolated after sacrifice, weighed, and normalized to body
weights on the day of sacrifice.
Hypothalamic slice preparation
Hypothalamic brain slices were prepared within 2 hr
after the fourth treatment as previously described [26]
and used for single cell real-time RT-PCR or electro-
physiological recording. After anesthesia, each rat was
perfused transcardially with the ice-cold sucrose-rich
artificial cerebrospinal fluid (ACSF) containing (in mM)
210 sucrose, 26 NaHCO3, 5 KCl, 1.2 NaH2PO4, 1.2
CaCl2, 2.4 MgCl2, and 10 glucose. The brains were
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slices (300 μm), including PVN regions, using a vibrating
tissue slicer (Vibratome 1000 plus, Vibratome Company,
St. Louis, MO, USA). The slices were incubated in an
oxygenated normal ACSF containing (in mM) 126 NaCl,
26 NaHCO3, 5 KCl, 1.2 NaH2PO4, 2.4 CaCl2, 1.2 MgCl2,
and 10 glucose for at least 1 hr at 30°C until used.
Single-cell real-time RT-PCR
To gain RNAs of PVN-RVLM neurons for real-time RT-
PCR, the hypothalamic brain slice was transferred to the
same recording chamber as that used for electrophysio-
logical recording, perfused continuously with an oxygen-
ated ACSF (4–5 ml/min), and maintained at 30–32°C.
The fluorescent-labeled PVN-RVLM neurons were visu-
alized by combining differential interference contrast
video microscopy with a fluorescence microscope in-
stalled with a green filter cube (WG, Olympus, Tokyo,
Japan). The cells were approached with patch pipettes,
using a micromanipulator (MP-225, Sutter instruments,
Novato, CA, USA), that were pulled from borosilicate
glass capillaries (1.7 mm diameter and 0.5 mm wall
thickness) and filled with nuclease-free water (Qiagen,
Valencia, CA, USA). After the whole cell configuration
was achieved, a slight negative pressure was applied to
pull the cytoplasm contents of each cell into the pip-
ette, taking care to avoid including the nucleus. Each
mixture of cytoplasm and water was immediately re-
moved into a prepared microtube containing (μl) 4 of
nuclease free water (Qiagen) and 1 of RNase Inhibitor
(Applied Biosystems, Foster City, CA, USA). Reverse
transcription for single-cell cDNA preparations was car-
ried out using High Capacity cDNA Reverse Transcription
Kits (Applied Biosystems) according to the manufacturer’s
instructions.
PCR amplification was induced with a fraction of
the single cell cDNA using the StepOnePlus System
(Applied Biosystems) with SYBR Green detection for
Kv4.2 and Kv4.3. SYBR Green detection was carried
out as previously described with a minor modification
[20]. The primer sequences were as follows: Kv4.2 (Gen-
Bank: NM031730) forward 5′-ACAAACGAAGGGCA-
CAGAAGA-3′, reverse 5′-CATGTAGGCATTTGCACT
TCCA-3′; Kv4.3 (GenBank: NM031739) forward 5′-A
ACGCAGGGCACAGAAGAAG-3′, reverse 5′-GGCATT
GGAGCTCCCTGTT-3′; and β-actin (GenBank: NM031144)
forward 5′-CATTGCTGACAGGATGCAGAA-3′ reverse
5′-AGAGCCACCAATCCACACAGA-3′. The real-time
PCR reactions contained (in μl): 2 of the cDNA tem-
plate, 0.2 of 10 μM of each forward and reverse primer,
0.4 of 50× Rox dye, 10 of 2× SYBR master mix (SYBR
premix Ex Taq, Takara Bio Inc., Japan), and nuclease free
water. The total volume was 20 μl. The thermal protocol
was as follows: pre-denaturation at 95°C for 10 sec,amplification composed of 50 cycles of denaturation at
95°C for 5 sec and annealing at 60°C for 25 sec, and
the melt curve step following the amplification, to ver-
ify the specificity of the PCR products. All samples
were run in duplicate. Negative controls were assessed
by running RT without the reverse transcript. Kv4.2
and Kv4.3 mRNA expression was compared between
the oil-group and the E2-group using relative quantita-
tive analysis [27]. The threshold cycle (Ct) value of
Kv4.2 and Kv4.3 was normalized to that of a reference
gene, β-actin, in identical cells. Final values were
expressed as the n-fold of Kv4.2 or Kv4.3 transcript
levels in the E2-group to those in the oil-group. Primer
efficiencies for each target and reference gene were
calculated from the formula E = 10[-1/slope] [28], where
slope was obtained from the relationship between ser-
ial cDNA dilutions and Ct values, resulting in 98% for
Kv4.2, 101% for Kv4.3, and 98% for β-actin. The Ct
values of β-actin were similar across the cells (coefficient
of variation = 3%), between the groups, and among plates.
Electrophysiological recording
A brain slice was placed in a recording chamber and
perfused, and the fluorescent-labeled PVN-RVLM neu-
rons were visualized as described above (see Single-cell
real-time RT-PCR). Patch pipettes were prepared from
the same glass capillaries as above, but filled with the in-
ternal solution containing (in mM) 135 K-gluconate, 5
KCl, 20 HEPES, 0.5 CaCl2, 5 EGTA, and 5 MgATP (the
pH was adjusted to 7.2 with KOH). The open resistance
of the pipette ranged from 3 to 7 MΩ. The Axoclamp
2B amplifier (Molecular Devices, Foster City, CA, USA)
was used for whole cell recordings. The signals were fil-
tered at 1 kHz and digitized at 10 kHz using an analog-
digital converter (Digidata 1320A, Molecular Devices)
and pClamp software (Version 9.0, Molecular Devices).
The liquid junction potential (~14.3 mV) was corrected
for further analysis.
IA recordings were obtained in voltage clamp mode.
To isolate IA, the modified ACSF was used, containing
(in mM) 109 NaCl, 26 NaHCO3, 5 KCl, 1.2 NaH2PO4,
3.6 MgCl2, and 10 glucose plus 0.2 CdCl2, 3 EGTA, 30
tetraethylamonium (TEA), and 0.5 μM tetrodotoxin
(TTX) to block calcium channels, delayed rectifier po-
tassium channels, and voltage-gated sodium channels.
The protocols consisted of depolarizing step pulses, ran-
ging from -70 mV to +25 mV for 400 ms in 5 mV incre-
ments, from conditioning pulse to -90 mV or to -40 mV
for 340 ms, as described previously [14]. Currents ob-
tained from two different conditioning pulses were sub-
tracted digitally using pClamp software. To verify that
the obtained K+ current was transient A-type, 4-
aminopyridine (4-AP; 5 mM) was applied at the end
of the recording. IA amplitudes were used for the
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current densities. Activation curves were plotted with
normalized chord conductance, versus step poten-
tials, obtained by dividing the current amplitude by
differences between each step potential and reversal
potential of K+ ions (obtained from the Nernst equa-
tion; -87.04 mV); they were then fitted with the
Boltzmann equation using OriginPro 8 (OriginLab
Corporation, Northampton, MA, USA). Current densities
were calculated by dividing IA amplitudes by cell capaci-
tances. Inactivation characteristics of IA were analyzed
using the protocol of conditioning step pulses, ranging
from -120 mV to -35 mV for 50 ms in 5 mV increments,
and successive depolarizing pulses to -10 mV for IA activa-
tion, as described previously [14]. Inactivation curves were
plotted with normalized current amplitudes versus condi-
tioning step potentials, and fitted with the Boltzmann
equation. Differences in voltage dependences of IA activa-
tion and inactivation between the oil-group and the
E2-group were analyzed by comparing the half-activation
potential (V1/2, at which half of the IA is activated), the
slope factor obtained from the activation curve, the half-
inactivation potential (V1/2, at which half of the IA is inac-
tivated), and slope factor obtained from the inactivation
curve.
To investigate the effects of E2 on the membrane ex-
citability of PVN-RVLM neurons, delays to action po-
tential generation were examined in current-clamp mode
for both the oil- and E2-groups. The cells were hyperpo-
larized to near -90 mV, and depolarized by injecting a +45
pA current. The delay time was determined by measuring
the duration from the point initiating depolarization to the
peak of the first action potential. All drugs were obtained
from Sigma-Aldrich except TTX (Tocris Bioscience,
Bristol, UK).Figure 1 Effects of E2 treatments on OVX rats. OVX rats were treated w
0.1 ml corn oil) for the oil-group and the E2-group, respectively. A, the body w
the ratio of body weight increase each day to the weight on the first day of t
days (*P < 0.05). B, the mean uterus weight was compared between the two
normalized to the body weight on the day of sacrifice. E2 treatment significanStatistical analysis
All values were expressed as means ± S.E.M. Compari-
sons between the oil-group and the E2-group were ana-
lyzed using an unpaired t-test. When necessary, analyses
included two-way ANOVAs with fisher LSD post hoc
test. Differences were considered significant at P < 0.05.
All statistical analyses were conducted using OriginPro 8
(OriginLab) or SPSS Statistics 20 (IBM Corporation,
Armonk, NY, USA).
Results
The effects of E2 treatments on OVX-rats
The mean serum E2 concentration measured after sacri-
fice was 25 ± 4 pg/ml in the oil-group (n = 9) and 59 ±
11 pg/ml in the E2-group (n = 9) and was significantly
different between the two groups (P < 0.05). Suppression
in body weight gain by the E2 treatment appeared sig-
nificantly on the third day (6.14 ± 0.42% (n = 14) for the
oil-group and 2.01 ± 0.52% (n = 10) for the E2-group,
*P < 0.05); a larger effect was evident on the fourth day
(8.37 ± 0.91% (n = 16) for the oil group and 1.39 ± 1.02
(n = 12) for the E2 group, *P < 0.05), as shown in Figure 1A.
Uteri were isolated after sacrifice and normalized to body
weights (uterus/body, mg/g). The mean normalized
uterus weight was larger in the E2-group (4.15 ±
0.33 mg/g, n = 12, *P < 0.05) than in the oil-group (0.51 ±
0.02 mg/g, n = 16), as shown in Figure 1B.
Retrograde labeling of PVN-RVLM neurons
To identify the PVN-RVLM neurons for recording and
single-cell real-time RT-PCR, fluorescent tracer was
injected into the RVLM of OVX-rats. After the animals
were sacrificed, the serial medulla slices (100 μm thick-
nesses) were examined to determine that the dye was
injected into the RVLM. A representative image of theith vehicle (corn oil, 0.1 ml) and 17β-estradiol-3-benzoate (25 μg/kg in
eight-gain rate was compared between the two groups by calculating
reatment. A significant difference appeared on the third and the fourth
groups. Uteri were isolated after sacrifice and weighed. The weight was
tly increased uterus weight (*P < 0.05).
Lee et al. BMC Neuroscience 2013, 14:134 Page 5 of 11
http://www.biomedcentral.com/1471-2202/14/134medulla slice, including the RVLM, is illustrated in Figure 2A.
A dye spot is present within the triangle frame, made by
the nucleus ambiguus, the spinal trigeminal nucleus, and
the pyramidal tracts, which was suggested as the guideline
for RVLM location [29]. Figure 2B illustrates the
fluorescent-labeled PVN-RVLM neurons in a rat hypo-
thalamic brain slice. The PVN-RVLM neurons were lo-
cated primarily in the three main PVN subdivisions:
the dorsal cap (DC), the ventral parvocellular (PaV),
and the posterior parvocellular (PaPo), which was con-
sistent with the previous report [13].
E2 effects on the mRNA expression density of Kv4.2 and
Kv4.3 in single PVN-RVLM neurons
To investigate the effect of E2 on the mRNA expression
of Kv4.2 and Kv4.3 in rat PVN-RVLM neurons, single-
cell real-time RT-PCR was performed. The mRNA ex-
pression density of the target genes of the PVN-RVLM
neurons was compared between the oil-group and the
E2-group using the formula 2-ΔCt (Figure 3B), and then
analyzed using the 2-ΔΔCt method (Figure 3C), in which
the mRNA expression density of Kv4.2 and Kv4.3 in the
E2-group was expressed as n-fold that of the oil-group.
The Kv4.2 decreased 0.54 ± 0.06 fold in the E2-group
(n = 21; *P < 0.05) compared to that of the oil-group (n =
19; Figure 3C). However, Kv4.3 showed an unremarkable
difference between the E2-group (1.00 ± 0.18 fold, n = 31)
and the oil-group (n = 23). The mRNA expression density
of Kv4.2 and Kv4.3 was analyzed according to the subdivi-
sions where the PVN-RVLM neurons were distributed.
The PVN-RVLM neurons used in each subdivision are il-
lustrated in Figure 3A. As shown in Figure 3C, the cells in
the DC displayed more prominent reductions in Kv4.2
mRNA expression by E2 (0.29 ± 0.05 fold, n = 8 in the
E2-group and n = 4 in the oil group; *P < 0.05) than
those in other subdivisions (in the PaV, 0.89 ± 0.15 fold,
n = 8 in the E2-group and n = 6 in the oil group; in the
PaPo, 0.51 ± 0.09 fold, n = 5 in the E2-group and n = 9
in the oil-group). In contrast, Kv4.3 mRNA expression
densities exhibited the smallest differences in the DCFigure 2 Retrograde labeling of PVN-RVLM neurons. A, RVLM injection
thickness). The representative image shows that a fluorescent spot was con
ambiguus; sp, the spinal trigeminal nucleus; py, pyramidal tracts; scale bar =
neurons were located in the medial region (a) and in the posterior region
PVN-RVLM neurons are evident primarily in the dorsal cap (DC), the ventral
3 V, the third ventricle; scale bar = 200 μm.(0.87 ± 0.15 fold, n = 12 in the E2-group; n = 9 in the
oil group). In the PaV, Kv4.3 decreased 0.56 ± 0.15 fold
in the E2-group (n = 9) compared to that of the oil
group (n = 8), while in the PaPo, it increased 1.70 ±
0.51 fold in the E2-group (n = 10) compared to that of
the oil group (n= 6), but the differences were not significant.
E2 effects on IA in PVN-RVLM neurons
To examine a change in electrophysiological properties of
PVN-RVLM neurons as a result of E2, a whole cell clamp
recording was performed with 67 PVN-RVLM neurons, 36
cells from the oil-group and 31 cells from the E2-group.
The resting membrane potential (RMP), the input resist-
ance (Rin), and the membrane capacitance (Cm) showed no
differences between the two groups (RMP, −60.55 ±
0.67 mV in the oil-group and −60.36 ± 0.92 mV in the
E2-group; Rin, 492.89 ± 47.10 MΩ in the oil-group and
500.08 ± 42.73 MΩ in the E2-group; Cm, 35.23 ±
2.16 pF in the oil-group and 36.19 ± 1.92 pF in the E2-
group).
The study investigated possible IA modulation by E2. To
verify that the current recorded in this experiment was IA,
4-AP, the blocker of IA, was applied to the bath solution at
the end of recording. When 30 cells were tested, 68% of IA
peak amplitudes were blocked by 5 mM 4-AP (Figure 4A,
inset on right). The IA current densities (the normalized
current amplitude to cell capacitance) significantly de-
creased in the E2-group compared to those of the oil-
group (Figure 4B, *P < 0.05). However, the voltage-
dependence of IA activation and inactivation was not
different between the two groups (Figure 4C: for acti-
vation, V1/2 -18.84 ± 0.92 mV, slope factor 11.79 ± 0.38
(n = 36) in the oil-group and V1/2 -16.69 ± 1.04 mV,
slope factor 11.22 ± 0.45 (n = 31) in the E2-group; for
inactivation, V1/2 -69.14 ± 1.19 mV, slope factor 10.92 ± 0.41
(n = 33) in the oil-group and V1/2 -71.24 ± 1.71 mV, slope
factor 10.84 ± 0.47 (n = 28) in the E2-group).
When the maximal current densities of IA (at +25 mV
step potential) were compared between the oil-group
and the E2-group, the E2-group expressed significantlysite was verified with serial medulla slices including RVLM (100 μm
fined to the triangular frame defined as RVLM [29]. Amb, nucleus
1 mm. B, the fluorescent image illustrates that the labeled PVN-RVLM
(b) of the PVN in the hypothalamic brain slices (300 μm thickness). The
parvocellular (PaV), and the posterior parvocellular (PaPo) subdivisions.
Figure 3 E2 effects on mRNA expression density of Kv channel subunits in single PVN-RVLN neurons. For relative quantification of Kv4.2
and Kv4.3 mRNA expression in the PVN-RVLM neurons between the oil- and the E2- groups, single-cell real-time RT-PCR was performed. A,
the location of the PVN-RVLM neurons used for single-cell real-time RT-PCR in each subdivision. DC, the dorsal cap subdivision; PaV, the
ventral parvocellular subdivision; PaPo, the posterior parvocellular subdivision. B, The mRNA expression density of the target genes of
PVN-RVLM neurons was compared between the oil-group and the E2-group using the formula 2-ΔCt. C, the mRNA density of Kv4.2 and Kv4.3
was analyzed using the 2-ΔΔCt method and was finally expressed as n-fold that of the oil-group. The Kv4.2 significantly decreased, 0.54 ± 0.06
fold, in the E2-group (n = 21, *P < 0.05) compared to that of the oil-group (n = 19). However, Kv4.3 was not expressed differently between
the two groups. The mRNA expression densities of Kv4.2 and Kv4.3 were compared in the three different subdivisions: the DC, the PaV,
and the PaPo. In the DC, Kv4.2 mRNA expression significantly decreased in the E2-group, compared to that of the oil group, and decreased more
dominantly than in overall expression. In the PaV and PaPo, no significant differences were detected. Kv4.3 mRNA expressions were not statistically
different between the two groups for any subdivisions.
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(24.3 ± 1.39 pA/pF for the E2 group and 29.0 ± 1.33 pA/
pF for the oil-group, Figure 4D (a), *P < 0.05). The differ-
ential modulation in IA current density by E2 was exam-
ined according to the different subdivisions, as shown in
the mRNA expression analysis. A significant reduction
in IA current density occurred only in the DC (22.23 ±
2.04 pA/pF, n = 9 for the E2-group; 28.33 ± 1.79 pA/pF,
n = 16 for the oil-group; Figure 4D (b), *P < 0.05); other
subdivisions did not have similar significant changes (in
the PaV, 25.20 ± 2.75 pA/pF (n = 9) in the E2-group and
28.03 ± 4.52 pA/pF (n = 6) in the oil-group, Figure 4D
(c); in the PaPo, 25.22 ± 2.38 pA/pF, (n = 13) in the E2-
group and 30.07 ± 2.11 pA/pF (n = 14) in the oil-group,
Figure 4D (d)).E2 effects on delay of excitation in PVN-RVLM neurons
The study investigated E2 modulation of the membrane
excitability of PVN-RVLM neurons by comparing delays
in the onset of the first action potential between the
oil-group and the E2-group. When hyperpolarized to
near -90 mV and depolarized by injecting a +45 pA
current, most cells generated action potentials. How-
ever, delay durations to the onset of the first action po-
tential were different between the oil-group and the
E2-group (Figure 5A). Delays significantly shortened in
the E2-group (22.41 ± 2.37 ms, n = 17; *P < 0.05) com-
pared to that of the oil-group (35.35 ± 5.10 ms, n = 23,
Figure 5B). As the extent of hyperpolarization for re-
moving IA inactivation may influence delay durations,
hyperpolarizations were compared between the two
Figure 4 E2 effect on IA in PVN-RVLM neurons. A, representative images illustrate IA isolated in PVN-RVLM neurons from the oil-group (left)
and the E2-group (right). The left inset indicates the voltage protocol used to isolate IA. The right inset indicates the reduction in IA by 4-
aminopyridine (4-AP), the blocker of IA. B, Plots of IA current densities versus command step potentials. The current density was calculated by
dividing the current amplitude of IA by cell capacitance. The E2 group (filled squares) displayed significant reductions in current densities of
IA, compared to the oil-group (open squares). *P < 0.05. C, activation curve plotted with the mean normalized chord conductance (open squares
for the oil-group and filled squares for the E2-group) and inactivation curve plotted with the mean normalized amplitude (open circles for the
oil-group and filled circles for the E2-group). The curves were fitted with the Boltzmann equation. There were no significant differences in either
the activation or the inactivation properties of IA. D, the maximal current density (at +25 mV step potential) was compared between the two
groups. (a) In the E2-group, the maximal current density of IA significantly decreased, compared to that of the oil-group. When the differences
between the two groups were compared according to subdivisions, a significant difference was detected only in the DC (b), not in either the
PaV (c) or the PaPo (d). *P < 0.05. Insets in (b), (c) and (d) indicate the locations of the PVN-RVLM neurons used for IA recording in each subdivision.
DC, the dorsal cap subdivision; PaV, the ventral parvocellular subdivision; PaPo, the posterior parvocellular subdivision.
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the oil group and 88.50 ± 1.05 mV in the E2-group).
Discussion
The biophysical and pharmacological properties of the
PVN-RVLM neurons, known as presympathetic neu-
rons, have been extensively studied in physiological and
pathological conditions [14,19,30]. It has also been demon-
strated that ER, especially ER-β, is substantially expressedin the PVN-RVLM neurons [13] suggesting specific roles
of E2 in the PVN-RVLM neurons. However, the effects of
E2 on the cellular properties of PVN-RVLM neurons re-
main unknown. The present study investigated differences
in the cellular properties of PVN-RVLM neurons between
estrogen-deficient rats (the oil-group) and estrogen-
replaced rats (the E2-group) following E2 treatment
in vivo after ovariectomy. The investigation focused on
Kv channel subunit expression and its functional current,
Figure 5 E2 effects on delay of excitation in PVN-RVLM
neurons. A, a representative image shows a delay in the onset of
the first action potential expressed in PVN-RVLM neurons from the
oil-group (dashed line) and the E2-group (solid line). The cells were
hyperpolarized to near -90 mV to remove IA inactivation and
depolarized by injecting a +45 pA current. B, The bar graph summarizes
the differences in delay in the onset of the first action potential
between the oil-group and the E2-group. The mean delay time of
the E2-group significantly decreased, compared to that of the
oil-group (*P < 0.05).
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PVN-RVLM neurons, and Kv channel subunits are modu-
lated by altered physiological conditions [14,19]. The re-
sults showed that E2 significantly down-regulated the
mRNA expression of Kv4.2, but not that of Kv4.3, and di-
minished IA current density. Interestingly, this effect was
only observed in the DC among three subdivisions (DC,
PaV, and PaPo). E2 also shortened the delay in the onset
of the first action potential that is known to be associated
with IA in PVN neurons [21]. These results suggest that
E2 exerts an inhibitory effect on the function of IA, poten-
tially by selectively down-regulating the transcript levels of
Kv4.2 but not Kv4.3 in PVN-RVLM neurons distributed in
the specific subdivision. However, some limitations should
be considered in the present study. First, the electro-
physiological recording and single cell real-time RT-PCR
were performed in different cells rather than in the same
cells due to the poor quality of the RNA samples following
a long recording time and continuous exposure of the
cells to multiple ion channel blockers. Therefore, a direct
correlation between IA and Kv4.2 in E2-mediated regula-
tion cannot be confirmed. However, the observation that
the down-regulation by E2 of the mRNA expression of
Kv4.2 and the density of IA appeared consistent indicates
that Kv4.2 and IA are closely related/associated in the cel-
lular modulation of PVN-RVLM neurons. Second, the
mechanism underlying E2-mediated regulation of Kv4.2
and IA remains unclear. Future studies are warranted to
confirm whether ER-β located in the PVN-RVLM neurons
mediates the transcriptional regulation of Kv4.2. Third,
the possibility that non-genomic actions of E2 contributed
to Kv4.2 and IA modulation in the PVN-RVLM neuronscannot be excluded because it has been shown that acute
application of E2 in bath solution inhibits outward potas-
sium currents, including IA [31]. E2 induces non-genomic
events via membrane estrogen receptor or other E2-binding
proteins, which activate second messenger cascades, includ-
ing adenylate cyclase, phospholipase C, extracellular-signal-
regulated kinase, and mitogen-activated protein kinase
[32,33]. It was reported that inhibition of the IA density by
E2 replacement is reversed by application of a kinase
inhibitor in gonadotropin-releasing hormone neurons
of OVX-mice [34].
In spite of these limitations, this study is noteworthy
because it is the first to reveal estrogenic modulation of
cellular properties of PVN-RVLM neurons, particularly
its target gene selectivity, for example, for Kv4.2 but not
Kv4.3, and its regional selectivity in the DC subdivision.
The selectivity for Kv4.2 is interesting because the major
potential subunit for IA, to date, in the PVN-RVLM neu-
rons has been considered to be Kv4.3 [14,19] because
the latter is predominantly expressed in PVN-RVLM
neurons [14]. However, our previous study found that
Kv4.2 may also contribute to IA in PVN neurons, despite
its lower detection frequency compared to Kv4.3 [20].
The selective modulation of Kv4.2 by E2 suggests that
even less dominantly expressed subunits could be in-
volved in the cellular modulation or the functions of
PVN-RVLM neurons and that gene modulation is not
necessarily parallel to preponderance in the gene expres-
sion level. The target selectivity of E2 in the modulation
of Kv4.2 and Kv4.3 is evident in distinct cell types. In
heart cells, Kv4.3 was regulated by E2, whereas Kv4.2
was not [22,23]. In uterus cells, Kv4.2 and Kv4.3 were
both regulated simultaneously by E2 during pregnancy
[24,35]. In a GT1-7 cell line producing gonadotropin-
releasing hormones, Kv4.2 was regulated by E2 [25].
Kv4.1 was regulated by E2 in the hypothalamic arcuate
nucleus [36]. Therefore, estrogenic regulation has spe-
cific selectivity in molecular targeting, depending on dis-
tinct tissues or cells. This selectivity may be related to
the differential expression of ER subtypes in distinct tis-
sue. In the uterus and the heart, the expression of ER-α
is greater than that of ER-β, which is uncommon in
PVN-RVLM neurons.
Regional selectivity in E2-induced modulation of Kv4.2
mRNA expression suggests that the effect of E2 on the
PVN-RVLM neurons is likely to be different on each
subdivision. E2 significantly down-regulated Kv4.2 only
in the DC. This finding is consistent with the recording
data in which the IA density was significantly down-
regulated in the same division by E2, indicating that E2
modulation of PVN-RVLM neurons almost reflects the
effects of E2 in the DC. From this result, we speculate
that heterogeneous cells that have different sensitivities
and responses to E2 exist in PVN-RVLM neurons and
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regard, the DC subdivision is likely to be the specific re-
gion where E2 exerts inhibitory effects on IA functions
of PVN-RVLM neurons, potentially by down-regulating
Kv4.2. The specific modulation of E2 in the DC subdiv-
ision may be due to distinct properties of PVN-RVLM
neurons distributed in this subdivision. For example,
biochemical differences among subdivisions could ac-
count for this specific modulation. It has been reported
that spinally-projecting PVN neurons which are distrib-
uted in similar regions to the PVN-RVLM neurons have
different neurochemical characteristics according to sub-
divisions [37]. Dynorphin and oxytocin were detected in
all subdivisions, but the expression of enkephalin and
vasopressin was considerably lower in the DC compared
to other subdivisions. Immunohistochemical studies showed
that ER-β was abundantly double-labeled with oxytocin,
whereas it was not with vasopressin or corticotropin-
releasing hormone in PVN neurons [11,38]. Although
such neurochemical differences have not been reported
in PVN-RVLM neurons, the differences may be closely
related to the regional-specific modulation by E2 in
these neurons.
This study investigated the effects of E2 on the mem-
brane excitability of PVN-RVLM neurons by observing
changes in the delay of the onset of the first action po-
tential between the oil-group and the E2-group, because
IA is known to exert a hyperpolarizing effect on mem-
brane discharge to delay membrane excitation [39]. In
agreement with E2-mediated down-regulation of IA, the
results showed that the delay was shortened in the E2-
group. The delay has been referred to as a representative
characteristic of magnocellular PVN neurons because
these neurons apparently express a stronger IA, coinciden-
tally associated with a longer delay, than parvocellular
PVN neurons [21]. Although the parvocellular PVN-
RVLM neurons displayed much smaller delays than the
magnocellular neurons, the delays are regulated to a sig-
nificant extent by E2, and these are probably associated
with the regulation of IA. This suggests that reductions in
IA and in the delay of the onset of the action potential by
E2 influence the functions of PVN-RVLM neurons. How-
ever, the neuronal properties of PVN-RVLM neurons are
determined not only by IA, but also by a variety of other
factors. Regarding the intrinsic membrane property, other
ionic currents besides IA, including voltage-gated calcium
channels and small conductance calcium-activated potas-
sium channels, participate in determining the excitability
of PVN-RVLM neurons [15,40]. Studies have reported
that E2 modulates these channels in other neuronal cells
within the brain [41-43]. Research has also shown that
neuronal activity is governed not only by intrinsic mem-
brane properties, but also by the synaptic inputs of excita-
tory and inhibitory signals [30]. In addition, studies havedemonstrated that receptors underlying the excitatory and
inhibitory synaptic signals are also influenced by E2 in
other brain regions [44,45].
The aforementioned raises the question of how E2-
induced cellular modulation of PVN-RVLM neurons
influences cardiovascular regulation. Studies have demon-
strated that estrogen plays protective roles in the
pathological development of, and the incidence of, car-
diovascular disorders [46-48]. Accumulating evidence
shows that the neuronal activity of PVN-RVLM neu-
rons is elevated by enhancing the intrinsic membrane
activity or by eliminating inhibitory synaptic inputs in
cardiovascular diseases, such as hypertension and chronic
myocardial infarction [16,26,49]. Therefore, the E2-
mediated modulation of PVN-RVLM neurons shown
in this study (i.e., the diminution in IA density and the
likely enhancement of membrane excitability) seems to
be controversial with respect to the protective effects
of E2 on the cardiovascular system because the modi-
fied pattern is more likely to reinforce the increase in
neuronal excitability induced by abnormal cardiovas-
cular conditions. However, it should be noted that E2
exerts different effects, depending on differing cardio-
vascular conditions. For instance, increased E2 levels
during pregnancy induce hypertrophy, but E2 also attenu-
ates the development of pressure-overload hypertrophy
[22,50]. As the present study investigated E2-mediated
modulation under normal conditions, different results can
be expected under pathological conditions. This expect-
ation is supported by the fact that different molecular
targets were employed in the modulation of IA in the
PVN-RVLM neurons, depending on the modulating
sources involved. A reduction in IA in the PVN-RVLM
neurons resulted from E2 replacement or artificial
hypertension in a similar manner. Nevertheless, E2
down-regulated Kv4.2 mRNA levels, whereas hyperten-
sion down-regulated Kv4.3 [19]. Therefore, Kv4.2, as
the target of E2 actions, could be modulated in differ-
ent ways in PVN-RVLM neurons, according to normal
or pathological conditions. Estrogenic effects on PVN-
RVLM neurons modified by cardiovascular disorders
remain to be determined.
Conclusions
This study demonstrated that E2 modified the cellular
properties of PVN-RVLM neurons. E2 played an inhibi-
tory role in the IA function in PVN-RVLM neurons and
selectively down-regulated the mRNA expression of
Kv4.2 but not that of Kv4.3. The finding that this modu-
lation occurred predominantly in the DC subdivision
suggests that functionally-discrete PVN-RVLM neurons
may be distributed in specific subdivisions, indicating
that these subdivisions deserve the important consider-
ation in researching PVN-RVLM neurons. This study is
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RVLM neurons.
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